AstraZeneca and Roche battle for a cancer breakthrough Investors Chronicle 07:52 Thu, 11 Jun Article paywall
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer The Times of India 07:17 Thu, 11 Jun
ADA 2026: AstraZeneca To Move Fast On Obesity And Heart Pill Combinations Scrip Pharma Intelligence 17:47 Wed, 10 Jun
AstraZeneca anunță un nou medicament pentru slăbit pe care l-a dezvoltat și care a trecut cu succes de faza studiilor clinice. Medicamentul a ajutat pacienții să piardă până la 12% din greutatea corporală în aproximativ nouă luni. Biziday 16:56 Tue, 09 Jun
ADA26: AstraZeneca unveils positive data for Phase III-ready oral GLP-1RA Clinical Trials Arena 15:19 Tue, 09 Jun
AstraZeneca: farmaco anti-obesità promette, analisti vedono potenziale ulteriore Invezz 14:46 Tue, 09 Jun
STAT Plus: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more STAT 14:43 Tue, 09 Jun
AstraZeneca's obesity drug shows promise as analysts see upside beyond consensus Invezz 14:36 Tue, 09 Jun
Lung Cancer Research Foundation and AstraZeneca Announce Open Call for Research Proposals with Focus on Small Cell Lung Cancer PR Newswire (Press Release) 14:31 Tue, 09 Jun
Médicaments anti-obésité : résultats encourageants pour un comprimé d'AstraZeneca Sciences et Avenir 11:48 Tue, 09 Jun
ADA 2026: AstraZeneca Advances Oral GLP-1 Elecoglipron Into Phase III After Positive Trial Data Scrip Pharma Intelligence 21:49 Mon, 08 Jun
expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 21:40 Mon, 08 Jun
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 21:37 Mon, 08 Jun Article paywall
Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 21:29 Mon, 08 Jun Article paywall
Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio AstraZeneca (Press Release) 21:22 Mon, 08 Jun
AstraZeneca: Inteligenţa artificială accelerează dezvoltarea medicamentelor şi creşte şansele de succes Replica 22:06 Sun, 07 Jun
AstraZeneca: Inteligența artificială accelerează dezvoltarea medicamentelor și crește șansele de succes Profit.ro 10:02 Sun, 07 Jun
AstraZeneca: Inteligenţa artificială accelerează dezvoltarea medicamentelor Bursa.ro 07:23 Sun, 07 Jun
AstraZeneca Stresses Interconnected Disease Strategy In CVRM Scrip Pharma Intelligence 22:30 Fri, 05 Jun
Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge? Simply Wall St 22:24 Fri, 05 Jun
NYSE Content Update: AstraZeneca Celebrates Largest Transfer in NYSE History PR Newswire (Press Release) 13:57 Fri, 05 Jun
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions Proactive Investors (UK) 11:42 Wed, 03 Jun
Former AstraZeneca research base could become private healthcare facility Cheshire Live 06:19 Wed, 03 Jun
ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do Proactive Investors (UK) 15:06 Mon, 01 Jun
ASCO: AstraZeneca's Imfinzi, Imjudo duo shines in earlier-stage liver cancer FiercePharma 13:34 Mon, 01 Jun
FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy Pharmaceutical Technology 10:20 Mon, 01 Jun
ASCO26: AstraZeneca’s light chain amyloidosis shows subgroup benefit after Phase III trial Clinical Trials Arena 16:38 Fri, 29 May
US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial Proactive Investors (UK) 15:40 Fri, 29 May
CelLBxHealth enters service agreement with AstraZeneca, shares pop ShareCast 14:21 Fri, 29 May Article paywall
CelLBxHealth shares jump 36% after master services agreement with AstraZeneca Proactive Investors (UK) 09:03 Fri, 29 May
Astrazeneca's Imfinzi secures FDA approval, Ocado enters into partnership with Asda ShareCast 07:47 Fri, 29 May Article paywall
FDA oncology roundup: AbbVie’s rare cancer approval, AstraZeneca in breast cancer limbo Pharmaceutical Technology 07:44 Fri, 29 May
